EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

10.1038/s41467-020-19704-x

Saved in:

Bibliographic Details
Main Authors:	Bao, Y., Oguz, G., Lee, W.C., Lee, P.L., Ghosh, K., Li, J., Wang, P., Lobie, P.E., Ehmsen, S., Ditzel, H.J., Wong, A., Tan, E.Y., Lee, S.C., Yu, Q.
Other Authors:	MEDICINE
Format:	Article
Published:	Nature Research 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/199286
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-199286
record_format	dspace
spelling	sg-nus-scholar.10635-1992862024-11-10T22:53:03Z EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy Bao, Y. Oguz, G. Lee, W.C. Lee, P.L. Ghosh, K. Li, J. Wang, P. Lobie, P.E. Ehmsen, S. Ditzel, H.J. Wong, A. Tan, E.Y. Lee, S.C. Yu, Q. MEDICINE INST OF MOLECULAR & CELL BIOLOGY GENOME INSTITUTE OF SINGAPORE DUKE-NUS MEDICAL SCHOOL 10.1038/s41467-020-19704-x Nature Communications 11 1 5878 2021-08-25T14:04:30Z 2021-08-25T14:04:30Z 2020 Article Bao, Y., Oguz, G., Lee, W.C., Lee, P.L., Ghosh, K., Li, J., Wang, P., Lobie, P.E., Ehmsen, S., Ditzel, H.J., Wong, A., Tan, E.Y., Lee, S.C., Yu, Q. (2020). EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature Communications 11 (1) : 5878. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-020-19704-x 20411723 https://scholarbank.nus.edu.sg/handle/10635/199286 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Nature Research Scopus OA2020
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1038/s41467-020-19704-x
author2	MEDICINE
author_facet	MEDICINE Bao, Y. Oguz, G. Lee, W.C. Lee, P.L. Ghosh, K. Li, J. Wang, P. Lobie, P.E. Ehmsen, S. Ditzel, H.J. Wong, A. Tan, E.Y. Lee, S.C. Yu, Q.
format	Article
author	Bao, Y. Oguz, G. Lee, W.C. Lee, P.L. Ghosh, K. Li, J. Wang, P. Lobie, P.E. Ehmsen, S. Ditzel, H.J. Wong, A. Tan, E.Y. Lee, S.C. Yu, Q.
spellingShingle	Bao, Y. Oguz, G. Lee, W.C. Lee, P.L. Ghosh, K. Li, J. Wang, P. Lobie, P.E. Ehmsen, S. Ditzel, H.J. Wong, A. Tan, E.Y. Lee, S.C. Yu, Q. EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
author_sort	Bao, Y.
title	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
title_short	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
title_full	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
title_fullStr	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
title_full_unstemmed	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
title_sort	ezh2-mediated pp2a inactivation confers resistance to her2-targeted breast cancer therapy
publisher	Nature Research
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/199286
_version_	1821234288005218304

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

Similar Items